Skip to main content

Innovations in Antiparasitic Drug Discovery and Host–Pathogen Interfaces

  • 1,439

    Total views and downloads

About this Research Topic

This Research Topic is currently accepting articles, but is closing soon.

Background

Parasitic diseases pose an ongoing scientific and clinical challenge, especially when it comes to neglected pathogens such as Trypanosoma cruzi, Leishmania spp., and Toxoplasma gondii. Despite advances in fields like medicinal chemistry, bioinorganic chemistry, and pharmacology, the effective treatment of these parasitic diseases remains elusive. Modern approaches have allowed for the rational design of antiparasitic compounds through molecular targeting of redox enzymes, proteases, and parasite-specific metabolic pathways. Furthermore, pioneering biological models, including 3D multicellular spheroids and organ-on-a-chip devices, are revolutionizing our understanding of host-parasite interactions and providing means to evaluate potential therapeutics in settings that more accurately reflect physiological conditions.

This Research Topic aims to provide a multidisciplinary platform that underscores the synergetic potential of chemical innovation and advanced biological modeling in the fight against parasitic diseases. By gathering insights at the intersection of chemical synthesis, target-guided drug design, mechanistic exploration, and cutting-edge biological models, this Research Topic seeks to advance our understanding and foster new solutions in parasitic disease treatment. Specific goals include exploring new antiparasitic compounds, investigating target-based drug design, and integrating computational and biological analyses to develop innovative drug delivery and evaluation methods.

To gather further insights in drug discovery and evaluation for parasitic diseases, we welcome articles addressing, but not limited to, the following themes:

- Medicinal chemistry and the discovery of novel antiparasitic compounds, including organic, organometallic, hybrid, and natural product derivatives.

- Target-based drug design and mechanism of action investigations focused on enzymes, metabolic pathways, and redox balance.

- Development and application of innovative in vitro, ex vivo, and in vivo models for studying parasitic infections, such as 3D spheroids, organ-on-a-chip systems, and tissue explants.

- Exosome-based and nanotechnology-driven strategies for improved antiparasitic drug delivery.

- Integrative approaches combining computational modeling, electrochemistry, and biological assays to enhance drug discovery and evaluation.

We welcome original research, reviews, mini-reviews, and perspectives on the aforementioned subtopics.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Data Report
  • Editorial
  • FAIR² Data
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Parasitic diseases, Drug discovery, Medicinal chemistry, Organ-on-a-chip, and Exosome-based drug delivery.

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 1,439Topic views
View impact